Supplemental  ||| S:0 E:13 ||| FW
lipoic  ||| S:13 E:20 ||| FW
acid  ||| S:20 E:25 ||| FW
relieves  ||| S:25 E:34 ||| FW
post-weaning  ||| S:34 E:47 ||| FW
diarrhoea  ||| S:47 E:57 ||| FW
by decreasing  ||| S:57 E:71 ||| FW
intestinal  ||| S:71 E:82 ||| FW
permeability  ||| S:82 E:95 ||| FW
in  ||| S:95 E:98 ||| FW
rats  ||| S:98 E:103 ||| FW
Lipoic  ||| S:103 E:110 ||| FW
acid  ||| S:110 E:115 ||| FW
( ||| S:115 E:116 ||| -LRB-
LA ||| S:116 E:118 ||| NNP
)  ||| S:118 E:120 ||| -RRB-
is  ||| S:120 E:123 ||| VBZ
a  ||| S:123 E:125 ||| DT
naturally  ||| S:125 E:135 ||| RB
existing  ||| S:135 E:144 ||| VBG
substance  ||| S:144 E:154 ||| NN
which  ||| S:154 E:160 ||| WDT
widely  ||| S:160 E:167 ||| RB
distributed  ||| S:167 E:179 ||| VBN
in  ||| S:179 E:182 ||| IN
the  ||| S:182 E:186 ||| DT
cellular  ||| S:186 E:195 ||| JJ
membranes  ||| S:195 E:205 ||| NN
and  ||| S:205 E:209 ||| CC
cytosol  ||| S:209 E:217 ||| NN
of  ||| S:217 E:220 ||| IN
animal  ||| S:220 E:227 ||| JJ
cells ||| S:227 E:232 ||| NNS
.  ||| S:232 E:234 ||| .
Its  ||| S:234 E:238 ||| PRP$
intracellular  ||| S:238 E:252 ||| JJ
functions  ||| S:252 E:262 ||| NNS
include  ||| S:262 E:270 ||| VBP
quenching  ||| S:270 E:280 ||| VBN
of  ||| S:280 E:283 ||| IN
free  ||| S:283 E:288 ||| JJ
radicals  ||| S:288 E:297 ||| NNS
and  ||| S:297 E:301 ||| CC
repairing  ||| S:301 E:311 ||| VBG
oxidized  ||| S:311 E:320 ||| JJ
proteins ||| S:320 E:328 ||| NNS
.  ||| S:328 E:330 ||| .
The  ||| S:330 E:334 ||| DT
purpose  ||| S:334 E:342 ||| NN
of  ||| S:342 E:345 ||| IN
this  ||| S:345 E:350 ||| DT
study  ||| S:350 E:356 ||| NN
was  ||| S:356 E:360 ||| VBD
to  ||| S:360 E:363 ||| TO
evaluate  ||| S:363 E:372 ||| VB
the  ||| S:372 E:376 ||| DT
effects  ||| S:376 E:384 ||| NNS
of  ||| S:384 E:387 ||| IN
LA  ||| S:387 E:390 ||| NNP
on  ||| S:390 E:393 ||| IN
post-weaning  ||| S:393 E:406 ||| JJ
diarrhoea  ||| S:406 E:416 ||| NNS
using  ||| S:416 E:422 ||| VBG
a  ||| S:422 E:424 ||| DT
rat  ||| S:424 E:428 ||| JJ
model ||| S:428 E:433 ||| NN
.  ||| S:433 E:435 ||| .
Sixty  ||| S:435 E:441 ||| JJ
weaned  ||| S:441 E:448 ||| JJ
rats  ||| S:448 E:453 ||| NNS
were  ||| S:453 E:458 ||| VBD
fed  ||| S:458 E:462 ||| VBN
either  ||| S:462 E:469 ||| RB
a  ||| S:469 E:471 ||| DT
basal  ||| S:471 E:477 ||| JJ
diet  ||| S:477 E:482 ||| NN
or  ||| S:482 E:485 ||| CC
a  ||| S:485 E:487 ||| DT
LA-supplemented  ||| S:487 E:503 ||| JJ
diet ||| S:503 E:507 ||| NN
,  ||| S:507 E:509 ||| ,
or  ||| S:509 E:512 ||| CC
a  ||| S:512 E:514 ||| DT
zinc  ||| S:514 E:519 ||| NN
oxide  ||| S:519 E:525 ||| NN
( ||| S:525 E:526 ||| -LRB-
ZnO ||| S:526 E:529 ||| NNP
) ||| S:529 E:530 ||| -RRB-
-supplemented  ||| S:530 E:544 ||| JJ
diet  ||| S:544 E:549 ||| NN
as  ||| S:549 E:552 ||| IN
a  ||| S:552 E:554 ||| DT
positive  ||| S:554 E:563 ||| JJ
control ||| S:563 E:570 ||| NN
.  ||| S:570 E:572 ||| .
Rats  ||| S:572 E:577 ||| NNS
in  ||| S:577 E:580 ||| IN
the  ||| S:580 E:584 ||| DT
LA  ||| S:584 E:587 ||| NNP
and  ||| S:587 E:591 ||| CC
ZnO  ||| S:591 E:595 ||| JJ
groups  ||| S:595 E:602 ||| NNS
had  ||| S:602 E:606 ||| VBD
better  ||| S:606 E:613 ||| JJR
performance  ||| S:613 E:625 ||| NN
and  ||| S:625 E:629 ||| CC
reduced  ||| S:629 E:637 ||| JJ
incidence  ||| S:637 E:647 ||| NN
of  ||| S:647 E:650 ||| IN
diarrhoea  ||| S:650 E:660 ||| NNS
( ||| S:660 E:661 ||| -LRB-
p   ||| S:661 E:663 ||| NNP
< ||| S:663 E:664 ||| SYM
 0.05 ||| S:664 E:669 ||| NNP
) ||| S:669 E:670 ||| -RRB-
.  ||| S:670 E:672 ||| .
Both  ||| S:672 E:677 ||| DT
LA  ||| S:677 E:680 ||| NNP
and  ||| S:680 E:684 ||| CC
ZnO  ||| S:684 E:688 ||| JJ
treatments  ||| S:688 E:699 ||| NNS
enhanced  ||| S:699 E:708 ||| VBN
intestinal  ||| S:708 E:719 ||| JJ
homeostatic  ||| S:719 E:731 ||| NN
and  ||| S:731 E:735 ||| CC
architecture ||| S:735 E:747 ||| NN
,  ||| S:747 E:749 ||| ,
significantly  ||| S:749 E:763 ||| RB
decreased  ||| S:763 E:773 ||| VBD
urinary  ||| S:773 E:781 ||| JJ
lactulose  ||| S:781 E:791 ||| NN
to  ||| S:791 E:794 ||| TO
mannitol  ||| S:794 E:803 ||| VB
ratios  ||| S:803 E:810 ||| NNS
( ||| S:810 E:811 ||| -LRB-
p   ||| S:811 E:813 ||| NNP
< ||| S:813 E:814 ||| SYM
 0.05 ||| S:814 E:819 ||| NNP
)  ||| S:819 E:821 ||| -RRB-
and  ||| S:821 E:825 ||| CC
increased  ||| S:825 E:835 ||| VBD
the  ||| S:835 E:839 ||| DT
expression  ||| S:839 E:850 ||| NN
of  ||| S:850 E:853 ||| IN
the  ||| S:853 E:857 ||| DT
intestinal  ||| S:857 E:868 ||| FW
mucosal  ||| S:868 E:876 ||| FW
tight  ||| S:876 E:882 ||| FW
junction  ||| S:882 E:891 ||| FW
proteins  ||| S:891 E:900 ||| FW
occludin  ||| S:900 E:909 ||| FW
( ||| S:909 E:910 ||| -LRB-
OCLN ||| S:910 E:914 ||| NNP
)  ||| S:914 E:916 ||| -RRB-
and  ||| S:916 E:920 ||| CC
zonula  ||| S:920 E:927 ||| JJ
occludens  ||| S:927 E:937 ||| JJ
protein-1  ||| S:937 E:947 ||| NN
( ||| S:947 E:948 ||| -LRB-
ZO-1 ||| S:948 E:952 ||| NNP
)  ||| S:952 E:954 ||| -RRB-
( ||| S:954 E:955 ||| -LRB-
p   ||| S:955 E:957 ||| NNP
< ||| S:957 E:958 ||| SYM
 0.05 ||| S:958 E:963 ||| NNP
) ||| S:963 E:964 ||| -RRB-
.  ||| S:964 E:966 ||| .
LA  ||| S:966 E:969 ||| NNP
significantly  ||| S:969 E:983 ||| RB
increased  ||| S:983 E:993 ||| VBD
the  ||| S:993 E:997 ||| DT
activities  ||| S:997 E:1008 ||| NNS
of  ||| S:1008 E:1011 ||| IN
antioxidant  ||| S:1011 E:1023 ||| JJ
enzymes ||| S:1023 E:1030 ||| NN
,  ||| S:1030 E:1032 ||| ,
and  ||| S:1032 E:1036 ||| CC
reduced  ||| S:1036 E:1044 ||| JJ
glutathione  ||| S:1044 E:1056 ||| NN
while  ||| S:1056 E:1062 ||| IN
decreasing  ||| S:1062 E:1073 ||| VBG
the  ||| S:1073 E:1077 ||| DT
levels  ||| S:1077 E:1084 ||| NNS
of  ||| S:1084 E:1087 ||| IN
oxidative  ||| S:1087 E:1097 ||| JJ
glutathione  ||| S:1097 E:1109 ||| NN
and  ||| S:1109 E:1113 ||| CC
malondialdehyde  ||| S:1113 E:1129 ||| NN
in  ||| S:1129 E:1132 ||| IN
the  ||| S:1132 E:1136 ||| DT
intestinal  ||| S:1136 E:1147 ||| JJ
mucosa  ||| S:1147 E:1154 ||| NNS
( ||| S:1154 E:1155 ||| -LRB-
p   ||| S:1155 E:1157 ||| NNP
< ||| S:1157 E:1158 ||| SYM
 0.05 ||| S:1158 E:1163 ||| NNP
) ||| S:1163 E:1164 ||| -RRB-
.  ||| S:1164 E:1166 ||| .
Furthermore ||| S:1166 E:1177 ||| RB
,  ||| S:1177 E:1179 ||| ,
an  ||| S:1179 E:1182 ||| DT
in vitro  ||| S:1182 E:1191 ||| JJ
study  ||| S:1191 E:1197 ||| NN
indicated  ||| S:1197 E:1207 ||| VBD
that  ||| S:1207 E:1212 ||| DT
supplementation  ||| S:1212 E:1228 ||| NN
with  ||| S:1228 E:1233 ||| IN
LA  ||| S:1233 E:1236 ||| NNP
in  ||| S:1236 E:1239 ||| IN
IEC-6  ||| S:1239 E:1245 ||| CD
intestinal  ||| S:1245 E:1256 ||| CD
epithelial  ||| S:1256 E:1267 ||| CD
cells  ||| S:1267 E:1273 ||| NNS
significantly  ||| S:1273 E:1287 ||| RB
enhanced  ||| S:1287 E:1296 ||| VBN
the  ||| S:1296 E:1300 ||| DT
expression  ||| S:1300 E:1311 ||| NN
of  ||| S:1311 E:1314 ||| IN
OCLN  ||| S:1314 E:1319 ||| NNP
and  ||| S:1319 E:1323 ||| CC
ZO-1  ||| S:1323 E:1328 ||| CD
under  ||| S:1328 E:1334 ||| IN
hydrogen  ||| S:1334 E:1343 ||| JJ
peroxide-induced  ||| S:1343 E:1360 ||| JJ
oxidative  ||| S:1360 E:1370 ||| JJ
stress ||| S:1370 E:1376 ||| NN
.  ||| S:1376 E:1378 ||| .
Collectively ||| S:1378 E:1390 ||| RB
,  ||| S:1390 E:1392 ||| ,
these  ||| S:1392 E:1398 ||| DT
results  ||| S:1398 E:1406 ||| NNS
suggest  ||| S:1406 E:1414 ||| VBP
that  ||| S:1414 E:1419 ||| IN
LA  ||| S:1419 E:1422 ||| NNP
relieves  ||| S:1422 E:1431 ||| VBD
post-weaning  ||| S:1431 E:1444 ||| JJ
diarrhoea  ||| S:1444 E:1454 ||| NN
by  ||| S:1454 E:1457 ||| IN
reducing  ||| S:1457 E:1466 ||| VBG
intestinal  ||| S:1466 E:1477 ||| JJ
permeability  ||| S:1477 E:1490 ||| NN
and  ||| S:1490 E:1494 ||| CC
improving  ||| S:1494 E:1504 ||| VBG
antioxidant  ||| S:1504 E:1516 ||| JJ
indices ||| S:1516 E:1523 ||| NNS
.  ||| S:1523 E:1525 ||| .
